Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

NCT02553837 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02553837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2015
Completion date
July 31, 2022
Enrollment
317 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy